33.30 USD
↘ 0.21 (0.63%)AT CLOSE (11:59 AM EDT)
Viking Therapeutics, Inc
VKTXNASDAQ • USD
33.50
↗ 0.20 (0.60%)
POST MARKET (AS OF 07:58 PM EDT)
Post Market
AS OF 07:58 PM EDT
33.50
↗ 0.20 (0.60%)
Market: CLOSED
Shares of Viking Therapeutics, Inc (VKTX) are trading at $33.30. The technical outlook is "Strong Sell" and the fundamental picture shows "Neutral". Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Aug 6, 2026.
Open?$33.50
High?$34.20
Low?$33.10
Prev. Close?$33.51
Volume?1.3M
Avg. Volume?2.4M
VWAP?$33.48
Rel. Volume?0.55x
Bid / Ask
Bid?$33.11 × 7.2K
Ask?$33.69 × 300
Spread?$0.58
Midpoint?$33.40
Valuation & Ratios
Market Cap?3.9B
Shares Out?116.7M
Float?111.5M
Float %?96.1%
P/E Ratio?N/A
P/B Ratio?9.51
EPS?-$4.58
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
Employees
59
Market Cap
3.9B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2015-04-29
Address
9920 PACIFIC HEIGHTS BLVD, SUITE 500
SAN DIEGO, CA
Phone: 858-704-4660
SAN DIEGO, CA
Phone: 858-704-4660
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▲ Bullish(+1/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?50
Short Sent.?25
Piotroski F-Score?0/9Weak
Altman Z-Score?14.88Safe
Confidence?49%Low
Short InterestSqueeze Risk
Short % of Float?20.77%Squeeze Risk
Short Interest?23.2M
Days to Cover?9.8
Free Float111.5M
Avg Daily Volume2.4M
Settlement Date2026-07-15
Financial Health
Current Ratio?4.72Strong
Quick Ratio?4.72Strong
Cash Ratio?1.15Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 3 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?9.51HIGH▾
Peers75
S&P20
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-6.7CHEAP▾
Peers100
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-131.0%WEAK▾
Peers33
S&P3
ROA?-102.5%WEAK▾
Peers33
S&P3
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$3.8B
Fundamentals ratios updated end of day